Skip to main content

Table 5 Univariate analysis of C3a, C4a and C5a plasma levels in nAMD patients not responding, partially responding and completely responding to anti-VEGF Ab therapy

From: Higher plasma levels of complement C3a, C4a and C5a increase the risk of subretinal fibrosis in neovascular age-related macular degeneration

Variables (ng/ml)

Controls (mean ± SD)

Non responders (mean ± SD)

Partial responders (mean ± SD)

Complete responders (mean ± SD)

P value

n = 43

n = 4

n = 48

n = 44

Partial vs complete respondersa

C3a

11.95 ± 3.30

13.97 ± 3.94

15.61 ± 5.18

13.67 ± 3.45

0.041

C4a

68.91 ± 33.23

79.97 ± 75.52

120.85 ± 98.30

97.57 ± 64.80

0.147

C5a

8.34 ± 2.05

8.62 ± 2.47

9.31 ± 2.72

9.63 ± 2.80

0.654

  1. aIndependent samples t-test
  2. Bold P < 0.05
  3. SD standard deviation